Skip to main content

Seizure Risk Asessment for Epilepsy

Project description

Seizure risk assessment for epilepsy

Predicting epileptic seizures are crucial. MJN Neuroserveis has developed SERAS, a non-invasive, discrete and wearable device to alert users of a pending epileptic attack. The device, which comprises an earpiece, reads the electroencephalogram and alerts the user via mobile application. What's more, the device monitors the user's brain activity, logging key medical information, including the number of seizures suffered, their intensity and frequency. SERAS can help patients significantly reduce, if not avert accidents from seizures, allowing science and doctors to go a step further in the research of neurological pathologies. The project is expected to boost commercialisation plans and scale-up business to the goal of EUR 27 million turnover by 2025.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /natural sciences/computer and information sciences/internet/internet of things
  • /medical and health sciences/basic medicine/neurology/epilepsy
  • /social sciences/economics and business
  • /natural sciences/computer and information sciences/artificial intelligence

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

MJN NEUROSERVEIS SL
Address
Avenue Joan Carles 184 Planta Bjs Puerta Dr
17300 Blanes
Spain
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 797 810